Epigenetic Activity of Peroxisome Proliferator-Activated Receptor Gamma Agonists Increases the Anticancer Effect of Histone Deacetylase Inhibitors on Multiple Myeloma Cells

• Nassera Aouali ,

  * E-mail: Nassera.Aouali@lih.lu

  Affiliation Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg

  ⨯
• Angeliki Broukou,

  Affiliation Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg

  ⨯
• Manon Bosseler,

  Affiliation Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg

  ⨯
• Olivier Keunen,

  Affiliation Laboratory Neuro-Oncology, Norlux, Luxembourg Institute of Health (LIH), Strassen, Luxembourg

  ⨯
• Vincent Schlesser,

  Affiliation Laboratory of Hematology, Centre Hospitalier de Luxembourg (CHL), Strassen, Luxembourg

  ⨯
• Bassam Janji,

  Affiliation Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg

  ⨯
• Valerie Palissot,

  Affiliation Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg

  ⨯
• Philippe Stordeur,

  Affiliation Biotechnology Department, Experimental Infectious Diseases Platform, CER Group, Marloie, Belgium

  ⨯
• Guy Berchem

  Affiliations Laboratory of Experimental Hemato-Oncology, LHCE, Luxembourg Institute of Health (LIH), Strassen, Luxembourg, Laboratory of Hematology, Centre Hospitalier de Luxembourg (CHL), Strassen, Luxembourg

  ⨯